PROJECT MANAGEMENT | BUSINESS PROCESS | INVESTING | TRAVELING | VOLUNTEERING
-
Why InspireMD (NSPR) Stock May Be Getting So Little Promotion
A more careful look at silence as a possible signal, not proof There’s a question that follows logically from everything in this series about InspireMD (NSPR). You’ve read about the clinical data. The job postings. The strategic logic. The catalyst calendar. The architects. The syndicate of 48 institutions. And at the end of all of…
-
The Syndicate supporting the thesis of InspireMD (NSPR)
Why 48 Institutions are betting against the market on InspireMD (NSPR)? Don’t ask me! I am just a fellow retail investor that likes to produce analyses for his own enjoyment while looking for opportunities. But hear me out! When a single sophisticated investor puts money into a small company, well that’s interesting. When six specialized…
-
The Architects: The people building InspireMD (NSPR)
Why I have room to think that InspireMD isn’t just hiring, it’s preparing for a payoff. There’s a difference between a company that has a board and a company that has been deliberately assembled with the right people for a higher-stakes phase. Most small-cap medtech companies have boards filled with capable people who bring general…